Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer

British Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 621-626

  Honkoop, A H ^a   Van Diest, P J ^a   De Jong, J S ^a   Linn, S C ^a   Giaccone, G ^a   Hoekman, K ^a   Wagstaff, J ^a   Pinedo, H M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Locally advanced breast cancer; Neoadjuvant chemotherapy; Prognostic factor

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; GLYCOPROTEIN P; IMMUNOSUPPRESSIVE AGENT; PROTEIN P53;

ADULT; ADVANCED CANCER; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031975835     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.99     Document Type: Article

References (26)

1. Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK and McGuire WL (1993) Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85: 200-206
2. Beahrs OH, Henson DE, Hutter and RVP (1993) Handbook for Staging of Cancer. American Joint Committee on Cancer, 4th edn. JB Lippincot: Philadelphia
3. Bosman FT, De Goeij AFPM and Rousch M (1992) Quality control in immunocytochemistry: Experiences with the oestrogen receptor assay. J Clin Pathol 45: 120-124
4. Carter CI, Allen C and Hensonde (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181-187
5. Feldman LD, Hortobagyi GN, Budzar AU, Ames FC and Blumenschein GR (1986). Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 46: 2578-2581
6. Gardin G, Rosso R, Campora E, Repetto L, Naso C, Canavese G, Catturich A, Corvo R, Guenzi M, Pronzato P, Baldini E and Conte PF (1995) Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. Eur J Cancer 31A: 1428-1433
7. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O, Barbareschi M, Boracchi P, Marubibi E and Pozza F (1994a) Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466
8. Gasparini G, Boracchi P, Verderio P and Bevilacqua P (1994b) Cell kinetics in human breast cancer: comparison between the prognostic value of the cytofluorimetric S-phase fraction and that of the antibodies to Ki-67 and PCNA antigens detected by immunocytochemistry. Int J Cancer 57: 822-829
9. Hoekman K, Wagstaff J, Groeningen CJ Van, Vermorken JB, Boven E and Pinedo HM (1991) Effects of recombinant human granulocyte macrophage colony stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer. J Natl Cancer Inst 83: 1546-1553
10. Honkoop AH, Hoekman K, Wagstaff J, Groeningen CJ Van, Vermorken JB, Boven E and Pinedo HM (1996) Continuous infusion or subcutaneous injection of granulocyte macrophage colony stimulating factor; increased efficacy and reduced toxicity when given subcutaneously. Br J Cancer 74: 1132-1136
11. Honkoop AH, Pinedo HM, De Jong JS, Verheul HMW, Linn SC, Hoekman K, Wagstaff J and Diest PJ Van (1997) Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol 107: 211-218
12. Hortobagyi GN (1994) Multidisciplinary management of advanced primary and metastatic breast cancer. Cancer 74: 416-423
13. Isola J, Visakorpi T, Holli K and Kallioniemi O-P (1992) Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84: 1109-1117
14. Linn SC, Giaccone G, Diest PJ Van, Blokhuis WMD, Valk P Van Der, Kalken CK Van, Kuiper CM, Pinedo HM and Baak JPA (1995) Prognostic relevance of P-glycoprotein expression in breast cancer. Ann Oncol 6: 679-685
15. Linn SC, Honkoop AH, Hoekman K, Valk P Van Der, Pinedo HM and Giaccone G (1996) p53 and P-Glycoprotein are often coexpressed and are associated with poor prognosis in breast cancer. Br J Cancer 74: 63-68
16. McCready DR, Hortobagyi GN, Kau SW, Smith TL, Budzar AU and Balch CM (1989) The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 124: 21-25
17. Pinedo HM, Honkoop AH, Hoekman K, Boven E, Groeningen CJ Van, Meijer S, Njo KH, Meijer CJLM, Vermorken JB and Wagstaff J (1996) Improved disease-free survival (DFS) of patients with locally advanced breast cancer (LABC) using prolonged dose intensive neoadjuvant doxorubicin (A), cyclophosphamide (C) and GM-CSF (abstract 88). Proc Am Soc Clin Oncol 15: 67
18. Railo M, Nordling S, Boguslawsky K Von, Leivonen M, Kyllonen L and Smitten K (1993) Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 68: 579-583
19. Riou G, Le MG, Travagli JP, Levine AJ and Moll UM (1993) Poor prognosis of p53 gene mutation and nuclear overexpression of p53 protein in inflammatory breast carcinoma. J Natl Cancer Inst 85: 1765-1767
20. Rosen G, Capparos B, Huvos A, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Metha B and Urban C (1982) Preoperative chemotherapy for osteosarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221-1230
21. Rosen PP, Lesser ML, Arroyo CD, Cranor M, Borgen P and Norton L (1995) P53 in node-negative breast carcinoma: An immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J Clin Oncol 13: 821-830
22. Schneider J, Bak M, Efferth TH, Kaufmann M, Mattern J and Volm M (1989) P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer 60: 815-818
23. Shi S-R, Key ME and Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues. An enhancement method for immunohistochemical staining based on microwave oven healing of tissue sections. J Histochem Cytochem 39: 741-748
24. Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen L-C, Mayall BH and Smith HS (1992) Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers. J Natl Cancer Inst 84: 845-855
25. Valk P Van Der, Kalken CK Van, Ketelaars H, Broxterman HJ, Scheffer G, Kuiper CM, Tsuruo T, Lankelma J, Meijer CJLM, Pinedo HM and Scheper RJ (1990) Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Ann Oncol 1: 56-64
26. Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Eng J Med 324: 1-8